{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:01:37Z","timestamp":1770076897131,"version":"3.49.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1996,12,15]]},"abstract":"<jats:p>\n            <jats:italic>Background<\/jats:italic>\n            This investigation examines the effects of inotropic stimulation on myocardial blood flow (MBF) and glucose metabolism (MRGlc) in dysfunctional myocardium through the use of positron emission tomography (PET).\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods and Results<\/jats:italic>\n            Nineteen patients with chronic coronary artery disease and 12 normal volunteers were studied with\n            <jats:sup>13<\/jats:sup>\n            N-ammonia,\n            <jats:sup>18<\/jats:sup>\n            F-deoxyglucose, and PET and with two-dimensional echocardiography at baseline and during intravenous dobutamine (5 to 10 \u03bcg\/kg per minute). At rest, MBF in mismatch regions (n=10) averaged 0.53\u00b10.19 mL\/g per minute and increased by 41.4\u00b146.6% (\n            <jats:italic>P<\/jats:italic>\n            =.01) during dobutamine, whereas in match regions (n=16) MBF was 0.28\u00b10.09 mL\/g per minute at rest without an increase during dobutamine (26.4\u00b147.3%; NS). Myocardium with normal rest MBF was classified as normal remote (normal wall motion, n=8) or abnormal remote (abnormal wall motion, n=11). Dobutamine raised MBF similarly in normal subjects and in normal remote regions (by 82\u00b185% and 84\u00b142%,\n            <jats:italic>P<\/jats:italic>\n            &lt;.01) but by only 33\u00b134% in abnormal remote regions. MRGlc declined by 49\u00b128% (\n            <jats:italic>P<\/jats:italic>\n            &lt;.005) with dobutamine in the normal subjects, remained unchanged in normal and abnormal remote regions of the patients, but increased in mismatch and match regions (by 49\u00b174% and 46\u00b177%;\n            <jats:italic>P<\/jats:italic>\n            &lt;.05). Wall motion improved with dobutamine only in mismatch and abnormal remote regions but not in match regions.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            Blood flow\u2013metabolism mismatch patterns are not consistently associated with a fixed downregulation of MBF; the increased contractile work in response to dobutamine stimulation is associated with an increase in MBF and a greater reliance on glucose utilization, possibly reflecting acute ischemia or alterations in substrate selection by chronically dysfunctional myocardium. Importantly, functionally impaired though normally perfused myocardium frequently exists in chronic coronary artery disease patients and may represent repetitively stunned or, more likely, remodeled left ventricular myocardium.\n          <\/jats:p>","DOI":"10.1161\/01.cir.94.12.3146","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:34:42Z","timestamp":1339461282000},"page":"3146-3154","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":87,"title":["Effects of Dobutamine Stimulation on Myocardial Blood Flow, Glucose Metabolism, and Wall Motion in Normal and Dysfunctional Myocardium"],"prefix":"10.1161","volume":"94","author":[{"given":"Karl T.","family":"Sun","sequence":"first","affiliation":[{"name":"the Division of Nuclear Medicine and Biophysics, Department of Molecular and Medical Pharmacology and Division of Cardiology (operated for the US Department of Energy by the University of California under contract DE-FCO3-87ER60615), UCLA School of Medicine, University of California, Los Angeles, and Cedars Sinai Medical Center, Division of Cardiology (Y.-K.L., G.M.), Los Angeles, Calif."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Czernin","sequence":"additional","affiliation":[{"name":"the Division of Nuclear Medicine and Biophysics, Department of Molecular and Medical Pharmacology and Division of Cardiology (operated for the US Department of Energy by the University of California under contract DE-FCO3-87ER60615), UCLA School of Medicine, University of California, Los Angeles, and Cedars Sinai Medical Center, Division of Cardiology (Y.-K.L., G.M.), Los Angeles, Calif."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Krivokapich","sequence":"additional","affiliation":[{"name":"the Division of Nuclear Medicine and Biophysics, Department of Molecular and Medical Pharmacology and Division of Cardiology (operated for the US Department of Energy by the University of California under contract DE-FCO3-87ER60615), UCLA School of Medicine, University of California, Los Angeles, and Cedars Sinai Medical Center, Division of Cardiology (Y.-K.L., G.M.), Los Angeles, Calif."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuk-Kong","family":"Lau","sequence":"additional","affiliation":[{"name":"the Division of Nuclear Medicine and Biophysics, Department of Molecular and Medical Pharmacology and Division of Cardiology (operated for the US Department of Energy by the University of California under contract DE-FCO3-87ER60615), UCLA School of Medicine, University of California, Los Angeles, and Cedars Sinai Medical Center, Division of Cardiology (Y.-K.L., G.M.), Los Angeles, Calif."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Bo\u00a8ttcher","sequence":"additional","affiliation":[{"name":"the Division of Nuclear Medicine and Biophysics, Department of Molecular and Medical Pharmacology and Division of Cardiology (operated for the US Department of Energy by the University of California under contract DE-FCO3-87ER60615), UCLA School of Medicine, University of California, Los Angeles, and Cedars Sinai Medical Center, Division of Cardiology (Y.-K.L., G.M.), Los Angeles, Calif."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Maurer","sequence":"additional","affiliation":[{"name":"the Division of Nuclear Medicine and Biophysics, Department of Molecular and Medical Pharmacology and Division of Cardiology (operated for the US Department of Energy by the University of California under contract DE-FCO3-87ER60615), UCLA School of Medicine, University of California, Los Angeles, and Cedars Sinai Medical Center, Division of Cardiology (Y.-K.L., G.M.), Los Angeles, Calif."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Phelps","sequence":"additional","affiliation":[{"name":"the Division of Nuclear Medicine and Biophysics, Department of Molecular and Medical Pharmacology and Division of Cardiology (operated for the US Department of Energy by the University of California under contract DE-FCO3-87ER60615), UCLA School of Medicine, University of California, Los Angeles, and Cedars Sinai Medical Center, Division of Cardiology (Y.-K.L., G.M.), Los Angeles, Calif."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich R.","family":"Schelbert","sequence":"additional","affiliation":[{"name":"the Division of Nuclear Medicine and Biophysics, Department of Molecular and Medical Pharmacology and Division of Cardiology (operated for the US Department of Energy by the University of California under contract DE-FCO3-87ER60615), UCLA School of Medicine, University of California, Los Angeles, and Cedars Sinai Medical Center, Division of Cardiology (Y.-K.L., G.M.), Los Angeles, Calif."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(89)90685-6"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198604033141405"},{"key":"e_1_3_2_3_2","unstructured":"Czernin J Porenta G Rosenquist G Kuhle W De Groof M Krivokapich J Brunken R Mody F Phelps M Schelbert H. Loss of coronary perfusion reserve in PET ischemia. Circulation. 1991;84(suppl II):II-47. Abstract."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.85.1.1728489"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90236-I"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90745-5"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.88.1.8319357"},{"key":"e_1_3_2_8_2","first-page":"308","volume":"20","year":"1993","unstructured":"Choi Y, Brunken RC, Hawkins RA, Huang S-C, Buxton DB, Hoh CK, Phelps ME, Schelbert HR. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med. 1993;20:308-318.","journal-title":"Eur J Nucl Med"},{"key":"e_1_3_2_9_2","first-page":"1235","volume":"33","year":"1992","unstructured":"Kuhle W, Porenta G, Huang S-C, Phelps M, Schelbert H. Issues in the quantitation of reoriented cardiac PET images. J Nucl Med. 1992;33:1235-1242.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_10_2","first-page":"245","volume":"33","year":"1992","unstructured":"Porenta G, Kuhle W, Czernin J, Ratib O, Brunken RC, Schelbert HR. Interactive user-friendly image analysis of cardiac PET images on a low cost desktop computer. IEEE Trans Biomed Eng. 1992;33:245-248.","journal-title":"IEEE Trans Biomed Eng"},{"key":"e_1_3_2_11_2","first-page":"1628","volume":"33","year":"1992","unstructured":"Porenta G, Kuhle W, Czernin J, Ratib O, Brunken R, Phelps M, Schelbert H. Semiquantitative assessment of myocardial viability and perfusion utilizing polar map displays of cardiac PET images. J Nucl Med. 1992;33:1628-1636.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_12_2","first-page":"885","volume":"88","year":"1993","unstructured":"Czernin J, Porenta G, Brunken R, Krivokapich J, Chen K, Bennett R, Hage A, Fung C, Tillisch J, Phelps M, Schelbert H. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation. 1993;88:885-895.","journal-title":"Circulation"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.60.4.476879"},{"key":"e_1_3_2_14_2","first-page":"836","volume":"33","year":"1992","unstructured":"Czernin J, Mu\u00a8ller P, Kim A, Chan S, Porenta G, DeGroof M, Rosenqvist G, Chan A, Phelps M, Schelbert H. Myocardial flow reserve declines with age because of higher cardiac work at rest. J Nucl Med. 1992;33:836. Abstract.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_15_2","first-page":"577","volume":"23","year":"1982","unstructured":"Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med. 1982;23:577-586.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.86.3.1516170"},{"key":"e_1_3_2_17_2","first-page":"733","volume":"32","year":"1991","unstructured":"Choi Y, Hawkins R, Huang S, Gambhir S, Brunken R, Phelps M, Schelbert H. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. J Nucl Med. 1991;32:733-738.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.87.5.1513"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.90.2.8044942"},{"key":"e_1_3_2_20_2","first-page":"H1265","volume":"268","year":"1995","unstructured":"Depre C, Vanoverschelde JL J, Melin J, Borgers M, Bol A, Ausma J, Dion R, Wijns W. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol. 1995;268:H1265-H1275.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.57.6.416923"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0033-0620(81)90019-0"},{"key":"e_1_3_2_23_2","first-page":"152","volume":"38","year":"1976","unstructured":"Opie LH. Effects of regional ischemia on metabolism of glucose and fatty acids. Circ Res. 1976;38:152-174.","journal-title":"Circ Res"},{"key":"e_1_3_2_24_2","first-page":"129A","volume":"21","year":"1993","unstructured":"Chan A, Czernin J, Brunken R, Choi Y, Krivokapich J, Schelbert HR. Effects of fasting on the incidence of blood flow metabolism mismatches in chronic CAD patients. J Am Coll Cardiol. 1993;21:129A. Abstract.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_2_25_2","unstructured":"Schwaiger M Sun D Deeb G Nguyen N Haas F Sebening F Brosius FC. Expression of myocardial glucose transporter (GLUT) mRNAs in patients with advanced coronary artery disease (CAD). Circulation. 1994;90(suppl I):I-113. Abstract."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1971.tb07462.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.53.5.1260986"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"Merhige ME Ekas R Mossberg K Taegtmeyer H Gould KL. Catecholamine stimulation substrate competition and myocardial glucose uptake in conscious dogs assessed with positron emission tomography. Circ Res. 1987;61(suppl II):II-124-II-129.","DOI":"10.1161\/res.61.5_supplement.ii-124"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198207223070401"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.81.4.2138525"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8097594"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90245-8"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.87.3.8443896"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00431-O"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.83.2.1991369"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.4.796"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90554-P"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)00205-7"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.94.12.3146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T15:58:33Z","timestamp":1715529513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.94.12.3146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12,15]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1996,12,15]]}},"alternative-id":["10.1161\/01.CIR.94.12.3146"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.94.12.3146","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12,15]]},"assertion":[{"value":"1996-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-09-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}